MEDICINE

Urobak

25 mg/5 ml Oral Suspension · Nitrofurantoin

Indications

Urobak is specifically indicated for the treatment & prophylaxis of urinary tract infections caused by susceptible strains of Escherichia coli, Enterococci, Staphylococcus aureus, Staphylococcus saprophyticus and certain susceptible strains of Klebsiella and Enterobacter species.

Pharmacology

Nitrofurantoin is an antibacterial agent specific for urinary tract infections. Nitrofurantoin is highly soluble in urine, to which it may impart a brown color. Nitrofurantoin inactivates or alters bacterial ribosomal proteins and other macromolecules. Nitrofurantoin has been shown to be active against the following bacteria: Gram-Positive Aerobes Staphylococcus saprophyticus, Coagulase-negative staphylococci (including Staphylococcus epidermidis), Enterococcus faecalis, Staphylococcus aureus, Streptococcus agalactiae, Group D streptococci, Viridans group streptococci. Gram-Negative Aerobes- Escherichia coli, Citrobacter amalonaticus, Citrobacter diversus, Citrobacter freundii, Klebsiella oxytoca, Klebsiella ozaenae.

Dosage and administration

Nitrofurantoin tablet (In adults):

Uncomplicated urinary tract infections : 50-100 mg four times a day- the lower dosage level is recommended. Therapy should be continued for one week or for at least 3 days after sterility of the urine is obtained.

For long-term suppressive therapy : In adults, a reduction of dosage to 50-100 mg at bedtime may be adequate.

Nitrofurantoin capsule (In adults):

Acute Uncomplicated Urinary Tract Infections (UTIs) : 50 mg four times daily for 7 days.

Long term suppression : 50-100 mg once a day.

Prophylaxis : 50 mg four times daily for the duration of procedure and for three days thereafter.

Nitrofurantoin SR capsule:

Adults and Children over 12 years : One 100 mg capsule every 12 hours for seven days.

Genito-urinary surgical prophylaxis : One capsule twice daily on day of procedure and for next 3 days.

Nitrofurantoin suspension: Children: 5-7 mg/kg/day in four divided doses (contraindicated under one month of age). The average dose of Nintoin suspension for pediatric patients are as follows-

7 to 11 kg: ½ (2.5 ml) teaspoonfuls 4 times daily.

12 to 21 kg: 1 (5 ml) teaspoonfuls 4 times daily.

22 to 30 kg: 1½ (7.5 ml) teaspoonfuls 4 times daily.

31 to 41 kg: 2 (10 ml) teaspoonfuls 4 times daily.

Therapy should be continued for one week or for at least 3 days after sterility of the urine is obtained. For long-term suppressive therapy in children, doses as low as 1 mg/kg per 24 hours, given in a single dose or in two divided doses, may be adequate.

Interactions

Antacids containing Magnesium Trisilicate, when administered concomitantly with Urobak, reduce both the rate and extent of absorption of Uricosuric drugs, such as Probenecid and Sulfinpyrazone, can inhibit renal tubular secretion of Urobak.

Contraindications

Anuria, oliguria or significant impairment of renal function are contraindications. This drug is contraindicated in pregnant patients at 38-42 weeks, during labor and delivery. Nitrofurantoin is also contraindicated in those patients with known hypersensitivity to Nitrofurantoin.

Side effects

The most frequent clinical adverse events are nausea, headache, and flatulence. Other less occurred adverse events are diarrhea, dyspepsia, abdominal pain, constipation, emesis, dizziness and drowsiness.

Pregnancy and lactation

Pregnancy Category B. There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if clearly needed. Nitrofurantoin has been detected in human breast milk in trace amounts. Because of the potential for serious adverse reactions from Nitrofurantoin in nursing infants under one month of age, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

Precautions and warnings

If acute, sub-acute or chronic pulmonary reactions occur, Urobak should be discontinued. Antacid preparations containing magnesium trisilicate should not be taken while taking Urobak.

Overdose

Occasional incidents of acute overdosage of Urobak have not resulted in any specific symptoms other than vomiting. Induction of emesis is recommended.

Storage

Do not store above 30°C. Keep away from light and out of the reach of children.

Similar brands of Nitrofurantoin

Brands of Nitrofurantoin
#BrandCompanyFormStrengthPrice
1NitrofurACI LimitedOral Suspension25 mg/5 mlNot listed
2NintoinIncepta Pharmaceuticals Ltd.Oral Suspension25 mg/5 mlNot listed
3UritroTeam Pharmaceuticals Ltd.Oral Suspension25 mg/5 mlNot listed
4UmactinUniMed UniHealth Pharmaceuticals Ltd.Oral Suspension25 mg/5 mlNot listed
5UrocureSquare Pharmaceuticals PLCOral Suspension25 mg/5 mlNot listed
6NFTHealthcare Pharmaceuticals Ltd.Oral Suspension25 mg/5 mlNot listed
7NitrobacThe IBN SINA Pharmaceutical PLCOral Suspension25 mg/5 mlNot listed
8UmactinUniMed UniHealth Pharmaceuticals Ltd.Capsule50 mg৳ 4.00per unit
9Nitrofur SRACI LimitedCapsule (Sustained Release)50 mg৳ 4.00per unit
10UritroTeam Pharmaceuticals Ltd.Capsule (Sustained Release)50 mg৳ 4.00per unit
11NintoinIncepta Pharmaceuticals Ltd.Capsule50 mg৳ 4.00per unit
12EuronitEuro Pharma Ltd.Tablet100 mg৳ 5.00per unit
13RantoinDrug International Ltd.Tablet100 mg৳ 6.00per unit
14UrobakOpsonin Pharma Ltd.Tablet100 mg৳ 6.02per unit
15NintoinIncepta Pharmaceuticals Ltd.Tablet100 mg৳ 6.80per unit
16UmactinUniMed UniHealth Pharmaceuticals Ltd.Capsule100 mg৳ 8.00per unit
17NitrobacThe IBN SINA Pharmaceutical PLCCapsule (Sustained Release)100 mg৳ 20.00per unit
18Urobak SROpsonin Pharma Ltd.Capsule (Sustained Release)100 mg৳ 20.00per unit
19NFTHealthcare Pharmaceuticals Ltd.Capsule (Sustained Release)100 mg৳ 20.00per unit
20Utifin SRAristopharma Ltd.Capsule (Sustained Release)100 mg৳ 20.00per unit
21FurabacPopular Pharmaceuticals Ltd.Capsule (Sustained Release)100 mg৳ 20.00per unit
22Euronit SREuro Pharma Ltd.Capsule (Sustained Release)100 mg৳ 20.00per unit
23UritroTeam Pharmaceuticals Ltd.Capsule (Sustained Release)100 mg৳ 20.00per unit
24Urocure SRSquare Pharmaceuticals PLCCapsule (Sustained Release)100 mg৳ 20.06per unit
25Nintoin SRIncepta Pharmaceuticals Ltd.Capsule (Sustained Release)100 mg৳ 23.00per unit
26Ofuran SRPacific Pharmaceuticals Ltd.Tablet (Sustained Release)100 mg৳ 26.00per unit
27Nitrofur SRACI LimitedCapsule (Sustained Release)100 mg৳ 26.00per unit
See every brand of Nitrofurantoin →

Common questions

What is Urobak used for?

Urobak is specifically indicated for the treatment & prophylaxis of urinary tract infections caused by susceptible strains of Escherichia coli, Enterococci, Staphylococcus aureus, Staphylococcus saprophyticus and certain susceptible strains of Klebsiella and Enterobacter species.

What is the generic name of Urobak?

Urobak contains Nitrofurantoin, which belongs to the group: Systemic Urinary Anti- infective.

Who makes Urobak?

Urobak is marketed in Bangladesh by Opsonin Pharma Ltd..

How is Urobak taken?

Nitrofurantoin tablet (In adults): Uncomplicated urinary tract infections : 50-100 mg four times a day- the lower dosage level is recommended. Therapy should be continued for one week or for at least 3 days after sterility of the urine is obtained. Always follow your doctor's instructions.

What are the side effects of Urobak?

The most frequent clinical adverse events are nausea, headache, and flatulence. Other less occurred adverse events are diarrhea, dyspepsia, abdominal pain, constipation, emesis, dizziness and drowsiness.

Is Urobak safe in pregnancy?

Pregnancy Category B. There are no adequate and well-controlled studies in pregnant women. Ask your doctor before using it while pregnant or breastfeeding.

This page is general information and is not medical advice. It does not replace a registered doctor, and it is not a prescription or a recommendation to use any medicine or test. Prices are listed prices and may change. Always follow the advice of your doctor or pharmacist.